129 related articles for article (PubMed ID: 22042808)
21. Renal nerves: time for reassessment of their role in hypertension?
Fink GD; Osborn JW
Am J Hypertens; 2014 Oct; 27(10):1245-7. PubMed ID: 24871630
[No Abstract] [Full Text] [Related]
22. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.
Mahfoud F; Schlaich M; Kindermann I; Ukena C; Cremers B; Brandt MC; Hoppe UC; Vonend O; Rump LC; Sobotka PA; Krum H; Esler M; Böhm M
Circulation; 2011 May; 123(18):1940-6. PubMed ID: 21518978
[TBL] [Abstract][Full Text] [Related]
23. [Renal denervation as treatment option for hypertension].
Blankestijn PJ; Bots ML
Ned Tijdschr Geneeskd; 2016; 160():D629. PubMed ID: 27781967
[TBL] [Abstract][Full Text] [Related]
24. Expanding the indication spectrum: renal denervation in diabetes.
Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
[TBL] [Abstract][Full Text] [Related]
25. SPYRAL HTN-OFF MED study: Renal denervation in the spiral orbits of current results and future studies.
Tsioufis C; Dimitriadis K; Papademetriou V; Tousoulis D
Hellenic J Cardiol; 2017; 58(5):320-321. PubMed ID: 29056558
[No Abstract] [Full Text] [Related]
26. Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea.
Linz D; Mahfoud F; Linz B; Hohl M; Schirmer SH; Wirth KJ; Böhm M
Am J Hypertens; 2014 Oct; 27(10):1293-300. PubMed ID: 24622919
[TBL] [Abstract][Full Text] [Related]
27. [Interventional hypertension therapy in diabetes mellitus. Effects on blood pressure and glucose metabolism?].
Ewen S; Ukena C; Pöss J; Linz D; Böhm M; Mahfoud F
Herz; 2014 May; 39(3):325-30. PubMed ID: 24671666
[TBL] [Abstract][Full Text] [Related]
28. Acute effect of renal sympathetic denervation on blood pressure in refractory hypertensive patients with chronic kidney disease.
Kiuchi MG; Chen S; Graciano ML; Carreira MA; Kiuchi T; Andrea BR; Lugon JR
Int J Cardiol; 2015; 190():29-31. PubMed ID: 25912114
[No Abstract] [Full Text] [Related]
29. 3D-sympathetic renal denervation increases procedural efficacy in non-responders after percutaneous renal denervation: dream or reality with second generation of devices.
Versaci F; Nardi S; Trivisonno A; Olivieri C; Caranci F; Prati F
Int J Cardiol; 2014 Aug; 175(2):370-1. PubMed ID: 24820742
[No Abstract] [Full Text] [Related]
30. Eligibility for renal denervation in patients with resistant hypertension: when enthusiasm meets reality in real-life patients.
Savard S; Frank M; Bobrie G; Plouin PF; Sapoval M; Azizi M
J Am Coll Cardiol; 2012 Dec; 60(23):2422-4. PubMed ID: 23141491
[No Abstract] [Full Text] [Related]
31. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial.
Muxfeldt ES; Margallo V; Costa LM; Guimarães G; Cavalcante AH; Azevedo JC; de Souza F; Cardoso CR; Salles GF
Hypertension; 2015 Apr; 65(4):736-42. PubMed ID: 25601933
[TBL] [Abstract][Full Text] [Related]
32. Catheter-based arterial sympathectomy: hypertension and beyond.
Prince EA; Murphy TP; Hampson CO
J Vasc Interv Radiol; 2012 Sep; 23(9):1125-34; quiz 1134. PubMed ID: 22920976
[TBL] [Abstract][Full Text] [Related]
33. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
[TBL] [Abstract][Full Text] [Related]
34. Resistant Hypertension: Mineralocorticoid Receptor Antagonist or Renal Denervation?
Carey RM
Hypertension; 2016 Feb; 67(2):278-80. PubMed ID: 26693820
[No Abstract] [Full Text] [Related]
35. Transradial renal denervation for the treatment of resistant hypertension.
Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
[TBL] [Abstract][Full Text] [Related]
36. [Renal sympathetic denervation in refractory hypertension].
Sans Atxer L; Oliveras A
Med Clin (Barc); 2013 Mar; 140(6):263-5. PubMed ID: 23276614
[No Abstract] [Full Text] [Related]
37. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months.
Symplicity HTN-1 Investigators
Hypertension; 2011 May; 57(5):911-7. PubMed ID: 21403086
[TBL] [Abstract][Full Text] [Related]
38. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects.
Kjeldsen SE; Os I; Mahfoud F
EuroIntervention; 2013 May; 9 Suppl R():R7-9. PubMed ID: 23732159
[No Abstract] [Full Text] [Related]
39. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
Hering D; Marusic P; Walton AS; Lambert EA; Krum H; Narkiewicz K; Lambert GW; Esler MD; Schlaich MP
Hypertension; 2014 Jul; 64(1):118-24. PubMed ID: 24732891
[TBL] [Abstract][Full Text] [Related]
40. Renal denervation in hypertension: simplicity, or complexity?
Lantelme P; Courand PY; Bricca G
Arch Cardiovasc Dis; 2014; 107(8-9):421-3. PubMed ID: 25128935
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
